Ligritinib
Ligritinib (AB801) is an orally active AXL receptor tyrosine kinase inhibitor. Ligritinib blocks the downstream signaling pathway by inhibiting the kinase activity of AXL. Ligritinib can be used in cancer research, especially in combination with chemotherapy for non-small cell lung cancer (NSCLC) [1].
Product Specifications
CAS Number
[3024588-48-2]
Product Name Alternative
AB801
UNSPSC
12352005
Target
TAM Receptor
Related Pathways
Protein Tyrosine Kinase/RTK
Applications
Cancer-Kinase/protease
Field of Research
Cancer
Purity
98.08
Smiles
CC(C=CC=N1)=C1C(C=N2)=CC=C2C3=NNC4=NC=C(C=C43)C5=CC6=C(C=C5)CC[C@@H](CC6)N7C8COCC7C8
Molecular Formula
C33H32N6O
Molecular Weight
528.65
References & Citations
[1]Miles DH, et al. Discovery of AB801, a Potent and Selective Inhibitor of AXL Receptor Tyrosine Kinase for Use in Cancer Therapy. J Med Chem. 2025 Jun 12;68 (11) :10663-10676.
Shipping Conditions
Room Temperature
Storage Conditions
-20°C, 3 years; 4°C, 2 years (Powder)
Scientific Category
Reference compound1
Clinical Information
No Development Reported
Available Sizes
Curated Selection
Explore Other Products
Discover premium biology products from our extensive collection of 20M+ items
![Mouse Monoclonal SMN Antibody (2B1) [mFluor Violet 610 SE]](https://cdn.genprice.uk/genprice/uk/genprice5.webp)
MBS6279709-01 0.1 mL
C1orf144, NT (C1orf144, UPF0485 protein C1orf144, Putative MAPK-activating protein PM18/PM20/PM22) (MaxLight 405)
Ask
View Details MBS6279709-02 5x 0.1 mL
C1orf144, NT (C1orf144, UPF0485 protein C1orf144, Putative MAPK-activating protein PM18/PM20/PM22) (MaxLight 405)
Ask
View Details 